Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2019-12-03 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
AIHL assay kit demonstrates high clinical accuracy
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated December 3, 2019. The content announces positive clinical validation results for a specific diagnostic kit (Antibiotic Induced Hearing Loss assay kit) and includes quotes from the CEO. The presence of the RNS Number, the format, and the nature of the announcement (a material operational/product update) strongly indicate this is a regulatory news service announcement from the London Stock Exchange. Since it is a general regulatory announcement that doesn't fit specific categories like ER, DIV, or CAP, the most appropriate classification is the general regulatory filing category.
2019-12-03 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states 'RNS Number : 9013U' and the title is 'Result of AGM'. It details the outcome of the Annual General Meeting, showing proxy voting results for various resolutions, including receiving the Annual Report and approving remuneration. This content directly corresponds to the results of a shareholder vote following an AGM. Therefore, the most specific classification is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it mentions the AGM, the core content is the voting result, not the presentation (AGM-R) or the proxy solicitation materials (PSI). Since it is an official regulatory announcement format (RNS), DVA is the best fit.
2019-11-27 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a transaction (purchase) of shares by a person discharging managerial responsibilities (Non-Executive Chairman) and includes regulatory disclosure information (Article 19(3) of the EU Market Abuse Regulation). This structure perfectly matches the definition of Director's Dealing (insider trades) which is a specific type of regulatory disclosure. While it is distributed via RNS, the core subject matter is the director's transaction, making 'DIRS' the most specific classification. It is not a general regulatory filing (RNS) because it fits DIRS precisely.
2019-11-22 English
Hardman & Co Research: genedrive plc (GDR): Regulatory hurdle leaped: hearing loss assay
Report Publication Announcement Classification · 1% confidence The document is a short announcement (4202 characters) from 'Hardman & Co Research' regarding genedrive plc. The title mentions a 'Regulatory hurdle leaped: hearing loss assay' and the content summarizes a recent regulatory achievement (CE marking) and points to an 'NHS implementation study'. Crucially, the text explicitly states, 'Please click on the link below for the full report:'. This structure—a brief summary directing the user to an external link for the main content—fits the definition of a Report Publication Announcement (RPA), as it announces the availability of a research report rather than being the report itself (like an ER or IR). It is not a standard regulatory filing (like 10-K or MRQ) but an announcement of third-party research publication.
2019-11-21 English
Antibiotic Induced Hearing Loss Assay CE marking
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's news service (RNS). The content announces a significant business event: the Genedrive® MT-RNR1 ID kit receiving CE marking. This is a specific, material event announcement, not a comprehensive periodic report (like 10-K or IR) or a transcript. Since it is a general regulatory announcement that doesn't fit perfectly into categories like DIV, CAP, or MANG, and it is distributed via RNS, the most appropriate classification is the general regulatory filing category, RNS, especially given the explicit mention of RNS at the end.
2019-11-18 English
Notice of AGM and Change of Auditors
Report Publication Announcement Classification · 1% confidence The document is identified by the RNS Number and the header 'RNS Number : 3806S'. The content explicitly announces the 'Notice of AGM, Posting of Annual Report and Change of Auditors'. Crucially, it states that the '2019 Annual Report and Accounts and Notice of the 2019 Annual General Meeting ("AGM") have been posted to shareholders and are available on the Group's website'. According to Rule 2 (The "MENU VS MEAL" RULE), a short document announcing the publication of reports (like the Annual Report and AGM Notice) rather than containing the full content of those reports should be classified as a Report Publication Announcement (RPA). It also mentions the AGM, but the primary function here is announcing the availability of multiple documents.
2019-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.